AMCP Nexus 2020 Virtual Recap

By Xcenda

Did you miss our Xcenda and FormularyDecisions team at AMCP Nexus 2020 Virtual? You can still benefit from our participation at AMCP Nexus 2020 Virtual by connecting with our team about our commercialization solutions, our scientific posters, or get a FormularyDecisions demonstration. Let Xcenda help you effectively navigate today’s complex healthcare landscape and help you deliver the most distinctive body of evidence that demonstrates your value story.


Xcenda Continues Excellence in Innovative Research

View our posters first presented at AMCP Nexus 2020 Virtual.

AMCP Nexus 2020 Virtual Poster Presentation

Trends in Manufacturer Perceptions and Practices Regarding Pre-Approval Information

Xcenda co-authors: Jonny Clark, Janet Hughes, Claire Gorey, Amy Duhig, Jay Jackson

AMCP Nexus 2020 Virtual Poster Presentation

How Are Curative Therapies Defined by United States Payers?

Xcenda co-authors: Anuja Kanaskar, Linnea Tennant, Kimberly Gittings, Chelsey Campbell, Michelle Friedman, Amy Duhig

AMCP Nexus 2020 Virtual Poster Presentation

A Review of COVID-19-Related Food and Drug Administration Warning Letters

Xcenda co-authors: Preston Skersick, Andrew Gaiser, Jasmine Knight, Kellie Meyer

AMCP Nexus 2020 Virtual Poster Presentation

A Descriptive Analysis of Healthcare Decision Maker Engagement Patterns in Pre-Approval Information Exchange

Xcenda co-authors: Annie Chang, Minha Choi, Claire Gorey, Breanna Penzner, Jackie Gladman, Amy Duhig

AMCP Nexus 2020 Virtual Poster Presentation

Digital Therapeutics as a Medical Benefit: Emergence of Published Policies by Managed Care Organizations

Xcenda co-authors: Song Lee, Benjamin Parcher

Examining data on a tablet

FORMULARYDECISIONS FOR MANUFACTURERS

Exchange Information with Thousands of Payers 

Examining data on a tablet
Connect with the largest active online payer community in the US to share information throughout your product's lifecycle.
Examining data on a tablet

Maximizing patient access for your product.

Connect with our team to discuss your product's commercialization and access goals.